Malik Ajay, Bhatia Jasvinder Kaur, Sahai Kavita, Boruah Dibyajyoti, Sharma A
Brig Med, Delhi Area, C/o 56 APO, India.
Senior Adviser & Head (Pathology), Command Hospital (Eastern Command) Kolkata, India.
Med J Armed Forces India. 2022 Sep;78(Suppl 1):S96-S104. doi: 10.1016/j.mjafi.2021.03.024. Epub 2021 Jul 15.
Colorectal cancer (CRC) is one of the commonest cancers worldwide, with incidence rates in India being around 4%. It is a heterogeneous disease with multiple established prognostic factors. Ten to fifteen percent originate from microsatellite instability (MSI) pathway, characterized by defect in mismatch repair (MMR) gene. Identification of MMR defective protein is relevant for diagnosis, prognosis, and prediction. Certain clinical and histological features are known to be associated with defective MMR genes. The objectives of this study are to find the prevalence of MSI in CRC to identify features associated with MSI and assess the value of histopathology in predicting MSI.
We evaluated various clinical and histological parameters for identifying prognostically favorable colon cancers in a tertiary hospital. One hundred fifty colon cancers were evaluated, and MSI status was correlated with clinicopathologic variables.
The prevalence of MSI in CRC was found to be 11.3%. The factors associated with MSI were tumor differentiation, stage, tumor site, tumor size, tumor-infiltrating lymphocytes, Crohn's-like lymphoid reaction, and dirty necrosis. We have defined a "P" score for prediction of MSI using the clinicohistological parameters, which could be used to select patients who are to be tested for MSI.
Assessment of clinical and histopathological features will help in patient stratification and selection of patients for MSI testing. The evaluation is economical, reproducible, and easy to apply.
结直肠癌(CRC)是全球最常见的癌症之一,在印度的发病率约为4%。它是一种具有多种既定预后因素的异质性疾病。10%至15%起源于微卫星不稳定性(MSI)途径,其特征是错配修复(MMR)基因缺陷。MMR缺陷蛋白的鉴定对于诊断、预后和预测具有重要意义。某些临床和组织学特征已知与MMR缺陷基因相关。本研究的目的是确定CRC中MSI的患病率,识别与MSI相关的特征,并评估组织病理学在预测MSI方面的价值。
我们在一家三级医院评估了各种临床和组织学参数,以识别预后良好的结肠癌。对150例结肠癌进行了评估,并将MSI状态与临床病理变量进行了关联。
发现CRC中MSI的患病率为11.3%。与MSI相关的因素包括肿瘤分化、分期、肿瘤部位、肿瘤大小、肿瘤浸润淋巴细胞、克罗恩样淋巴反应和脏坏死。我们使用临床组织学参数定义了一个用于预测MSI的“P”评分,可用于选择进行MSI检测的患者。
评估临床和组织病理学特征将有助于患者分层和选择进行MSI检测的患者。该评估经济、可重复且易于应用。